BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 17969410)

  • 1. [Is irradiation of intact ileoinguinal lymph nodes necessary in radiochemotherapy for stage-III Hodgkin's disease?].
    Kanaev SV; Girshovich MM; Golovanov SG; Gershanovich ML
    Vopr Onkol; 2007; 53(4):453-5. PubMed ID: 17969410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical evaluation of combined treatment of stage III(B) Hodgkin's disease].
    Kanaev SV; Golovanov SG; Girshovich MM; Gershanovich ML
    Vopr Onkol; 2006; 52(5):525-30. PubMed ID: 17168360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of efficacy of chemoradiotherapy for Hodgkin's disease].
    Kanaev SV; Gershanovich ML; Pozharisskiĭ KM; Girshovich MM; Malinin AP; Golovanov SG
    Vopr Onkol; 2004; 50(6):652-7. PubMed ID: 15755057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Can extended induction chemoradiotherapy be effective in the combined treatment of stage IIIB Hodgkin's disease ?].
    Kanaev SV; Girshovich MM; Golovanov SG; Gershanovich ML
    Vopr Onkol; 2009; 55(5):562-5. PubMed ID: 20020650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: cure balanced against complications.
    Koontz BF; Kirkpatrick JP; Clough RW; Prosnitz RG; Gockerman JP; Moore JO; Prosnitz LR
    J Clin Oncol; 2006 Feb; 24(4):605-11. PubMed ID: 16446333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combination chemotherapy with total or subtotal lymphatic irradiation in the treatment of lymphogranulomatosis, stage IIIA or IIIB (based on five- and ten-year results)].
    Kanaev SV; Gershanovich ML; Malinin AP
    Vopr Onkol; 1997; 43(1):32-8. PubMed ID: 9133084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New prognostic factors in the treatment of patients with stage-III Hodgkin's disease].
    Girshovich MM; Kanaev SV; Pozharisskiĭ KM; Golovanov SG; Barbashov AI
    Vopr Onkol; 2010; 56(4):424-9. PubMed ID: 20968021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin's lymphoma: a question of field size.
    Campbell BA; Voss N; Pickles T; Morris J; Gascoyne RD; Savage KJ; Connors JM
    J Clin Oncol; 2008 Nov; 26(32):5170-4. PubMed ID: 18838714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Don't throw out the baby with the bathwater: on optimizing cure and reducing toxicity in Hodgkin's lymphoma.
    Yahalom J
    J Clin Oncol; 2006 Feb; 24(4):544-8. PubMed ID: 16446326
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
    Tan WY; Hu DS; Zeng FY; Song QB; Hu S; Wei L; Zhou LQ
    Ai Zheng; 2007 Dec; 26(12):1360-4. PubMed ID: 18076802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Site of relapse after chemotherapy alone for stage I and II Hodgkin's disease.
    Shahidi M; Kamangari N; Ashley S; Cunningham D; Horwich A
    Radiother Oncol; 2006 Jan; 78(1):1-5. PubMed ID: 16309770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Novel approaches to combination therapy of Hodgkin's disease].
    Kharchenko VP; Pan'shin GA; Datsenko PV; Sotnikov VM; Mel'nik IuD
    Vopr Onkol; 2005; 51(6):692-6. PubMed ID: 17037037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current role and future developments of radiotherapy in early-stage favourable Hodgkin's lymphoma.
    Eich HT; Müller RP
    Strahlenther Onkol; 2007 Dec; 183 Spec No 2():16-8. PubMed ID: 18167000
    [No Abstract]   [Full Text] [Related]  

  • 14. [Relevance of certain factors in the effectiveness of chemoradiotherapy for Hodgkin's disease].
    Kanaev SV; Gershanovich ML; Pozharisskiĭ KM; Girshovich MM; Golovanov SG
    Vopr Onkol; 2005; 51(1):56-9. PubMed ID: 15909808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [13 years' experience with the combined treatment of lymphogranulomatosis].
    Fokina NT
    Ter Arkh; 1988; 60(5):111-8. PubMed ID: 3175920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Total fractionated irradiation of the lymph nodes in stage III Hodgkin's disease].
    Simbirtseva LP; Filatova AM; Vinogradov VM
    Med Radiol (Mosk); 1987 May; 32(5):8-12. PubMed ID: 3295457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results of radiotherapy in patients with stage-II Hodgkin's lymphoma with mediastinal lymph node involvement].
    Il'in NV; Kovryzhkina TA; Akimov AA; Loviagin EV; Shenderova IA
    Vopr Onkol; 2003; 49(5):643-7. PubMed ID: 14682140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Primary treatment of early stage Hodgkin's disease].
    Molnár Z; Esik O; Illés A
    Orv Hetil; 2005 Jan; 146(2):57-61. PubMed ID: 15724953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Stage IIIa Hodgkin's disease: long follow-up perspective.
    Lister TA
    J Clin Oncol; 2008 Nov; 26(32):5144-6. PubMed ID: 18854554
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognostic value of the epithelial membrane antigen (EMA) in the case of Hodgkin's disease.
    Touhami H; Sotto JJ; Sotto MF; Couderc P; Keddari E; Brahimi S; Kubisz P
    Neoplasma; 1991; 38(4):433-7. PubMed ID: 1922575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.